Aydogmus Yasin, Uzun Salih, Gundogan Fatih C, Ulas Umit Hidir, Ebiloglu Turgay, Goktas Mustafa Tugrul
Department of Urology, Etimesgut Military Hospital, Ankara, Turkey.
Department of Ophthalmology, Etimesgut Military Hospital, Ankara, Turkey.
World J Urol. 2017 Mar;35(3):467-472. doi: 10.1007/s00345-016-1880-9. Epub 2016 Jun 16.
To evaluate the changes in dynamic pupillometry in patients with idiopathic overactive bladder (OAB).
The study included 40 female patients with idiopathic OAB and 40 healthy female volunteers as a control group. Demographic and clinical data were recorded. Dynamic pupillometric parameters were measured with a commercially available unit (MonPack One, Metrovision, France) at baseline and on the 30th day of treatment with an antimuscarinic treatment (drug-agent) (solifenacin 5 mg daily). Initial, minimum, maximum and mean pupil diameters, the latency and duration of contraction and dilatation of the pupil, the amplitude of contraction and dilatation velocity were automatically measured and compared between the groups.
There were no significant differences between two groups with respect to age and body mass index (p = 0.288, 0.755, respectively). The measurements of initial, minimum and mean pupil diameters were significantly lower in patients with OAB compared to healthy controls (p = 0.007, 0.002, 0.001, respectively). OAB patients had significantly longer latency of pupil dilatation, latency of pupil contraction and shorter duration of pupil contraction than control group (p = 0.028, 0.029, 0.021, respectively). After the antimuscarinic treatment, latency of pupil contraction, latency of pupil dilatation and duration of pupil contraction shortened significantly (all p < 0.001). Pupil dilatation velocity increased significantly during the treatment (p < 0.001).
The dynamic pupillometric findings in this study imply impaired autonomic dysfunction, mostly the increased parasympathetic action, in OAB patients and the modulatory effects of antimuscarinic treatment.
评估特发性膀胱过度活动症(OAB)患者动态瞳孔测量的变化。
本研究纳入40例特发性OAB女性患者,并选取40名健康女性志愿者作为对照组。记录人口统计学和临床数据。在基线时以及使用抗毒蕈碱药物(索利那新5毫克/日)治疗的第30天,使用市售设备(MonPack One,法国Metrovision公司)测量动态瞳孔测量参数。自动测量并比较两组的初始、最小、最大和平均瞳孔直径,瞳孔收缩和扩张的潜伏期及持续时间,收缩幅度和扩张速度。
两组在年龄和体重指数方面无显著差异(p分别为0.288和0.755)。与健康对照组相比,OAB患者的初始、最小和平均瞳孔直径测量值显著更低(p分别为0.007、0.002、0.001)。OAB患者的瞳孔扩张潜伏期、瞳孔收缩潜伏期显著长于对照组,瞳孔收缩持续时间显著短于对照组(p分别为0.028、0.029、0.021)。抗毒蕈碱治疗后,瞳孔收缩潜伏期、瞳孔扩张潜伏期和瞳孔收缩持续时间显著缩短(所有p<0.001)。治疗期间瞳孔扩张速度显著增加(p<0.001)。
本研究中的动态瞳孔测量结果提示,OAB患者存在自主神经功能障碍受损,主要是副交感神经作用增强,以及抗毒蕈碱治疗的调节作用。